BackGritstone Bio Overview

Gritstone Bio Current Cash

Gritstone Bio's current cash is $52M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$52.17M
↑ 25.98% YoYΔ $10.76M vs prior year quarter

Peer average

Loading

Gritstone Bio Current Cash History

Loading

Gritstone Bio vs. peers: Current Cash Comparison

Loading

Gritstone Bio Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Gritstone Bio (GRTS) FAQ

Gritstone Bio (GRTS) currently reports a current cash of $52M as of June 2024. That compares with $41M in the prior-year period — up 26.0% year over year. Use the charts on this page to explore Gritstone Bio's current cash history and peer comparisons.

Gritstone Bio's current cash increased from $41M to $52M — a 26.0% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gritstone Bio reported $52M in current cash as of June 2024. That compares with $41M in the prior-year period — up 26.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $52M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gritstone Bio, and consider following GRTS for alerts when major investors trade the stock.

Gritstone Bio is classified in the Healthcare sector. On current cash, it currently shows $52M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GRTS with unrelated industries.